Kathleen Warnecke
Directeur/Membre du Conseil chez CONSTELLATION PHARMACEUTICALS, INC.
Provenance du réseau au premier degré de Kathleen Warnecke
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kathleen Warnecke via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| AADI BIOSCIENCE, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| MorphoSys US, Inc. | Corporate Officer/Principal | ||
| ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Comptroller/Controller/Auditor | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| IGNYTA INC | Biotechnology | Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | General Counsel | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Purdue University | College/University | Graduate Degree | |
| University of Tilburg | College/University | Masters Business Admin | |
| Bucknell University | College/University | Undergraduate Degree | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KARA THER | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree | |
| University of South Carolina | College/University | Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | General Counsel | |
| University of Aberystwyth | College/University | Doctorate Degree | |
| KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| Fairfield University | College/University | Undergraduate Degree | |
Hollister Staffing, Inc.
 Hollister Staffing, Inc. Personnel ServicesCommercial Services Hollister Staffing, Inc. engages in the provision of recruiting services. It offers contract, contract-to-hire and direct hire placement solutions. The firm serves the accounting and finance, administrative and human resource, creative, technology, and sales and marketing sectors. The company was founded by Kip Hollister-Hyde in 1988 and is headquartered in Boston, MA. | Personnel Services | Human Resources Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| LANTHEUS HOLDINGS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Kyowa Hakko Kirin Pharma, Inc. | Corporate Officer/Principal | ||
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
| Harvard College | College/University | Undergraduate Degree | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | General Counsel | |
| University of Innsbruck | College/University | Doctorate Degree | |
MJH Healthcare Holdings LLC
 MJH Healthcare Holdings LLC Internet Software/ServicesTechnology Services MJH Healthcare Holdings LLC operates as a medical media company. Its services include creative, interactive, live events, clinical communication, promotional education, and market access. The company is headquartered in Cranbury, NJ. | Internet Software/Services | Director/Board Member | |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Biotechnology | Director/Board Member | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 40 |
| Suisse | 3 |
| Pays-Bas | 3 |
| Royaume-Uni | 3 |
| France | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 35 |
| Director/Board Member | 35 |
| Independent Dir/Board Member | 14 |
| President | 13 |
| Undergraduate Degree | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Emma Reeve | 18 |
| Mark Goldsmith | 14 |
| Jigar Raythatha | 13 |
| Steven Hoerter | 12 |
| Brendan Delaney | 11 |
| Elizabeth G. Trehu | 10 |
| Jeffrey Humphrey | 9 |
| Brenda J. Sousa | 7 |
| James E. Audia | 7 |
| Richard Mountfield | 7 |
| Karen Valentine | 6 |
| Lara Smith-Weber | 6 |
| Sarah Coughlin | 4 |
| Irina Apostolou | 4 |
| Patric Trojer | 2 |
- Bourse
- Insiders
- Kathleen Warnecke
- Connexions Sociétés
